Verastem, Inc. Payments of Stock Issuance Costs
Verastem, Inc. (VSTM) reported Payments of Stock Issuance Costs of $74.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-08-06
- Verastem, Inc. payments of stock issuance costs for the quarter ending 2025-06-30 was $5.07M, a 79761.44% increase year-over-year.
- Verastem, Inc. payments of stock issuance costs for the quarter ending 2025-03-31 was $74.00K.
- Verastem, Inc. payments of stock issuance costs for the quarter ending 2024-09-30 was $1.18M.
- Verastem, Inc. payments of stock issuance costs for the quarter ending 2024-06-30 was $6.35K, a 99.90% decline year-over-year.
- Verastem, Inc. payments of stock issuance costs for fiscal 2025 was $74.00K, a 93.72% decline from fiscal 2024.
- Verastem, Inc. payments of stock issuance costs for fiscal 2024 was $1.18M, a 81.44% decline from fiscal 2023.
- Verastem, Inc. payments of stock issuance costs for fiscal 2023 was $6.35M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 3 month as first filed | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $74.00K 10-K · filed 2026-03-04 | ||||
| 2025-06-30 | $5.07M 10-Q · filed 2026-08-06 | $5.07K 10-Q · filed 2025-08-07 | $5.15M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $74.00K 10-Q · filed 2026-08-06 | ||||
| 2024-12-31 | $1.18M 10-K · filed 2025-03-20 | ||||
| 2024-09-30 | $1.18M 10-Q · filed 2024-11-06 | $1.19M derived: sum of 2 quarters · filed 2025-11-04 | |||
| 2024-06-30 | $6.35K 10-Q · filed 2025-11-04 | ||||
| 2023-12-31 | $6.35M 10-K · filed 2026-03-04 | ||||
| 2023-06-30 | $6.35M 10-Q · filed 2024-11-06 | $8.25M derived: sum of 2 quarters · filed 2024-11-06 | |||
| 2023-03-31 | $1.90M 10-Q · filed 2023-05-09 | ||||
| 2021-09-30 | $73.00K 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |